HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 67,000 Value ($000) $4,509 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 74,028 Value ($000) $5,429 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 87,029 Value ($000) $4,527 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 206,641 Value ($000) $13,186 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 196,999 Value ($000) $9,419 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 124,011 Value ($000) $7,098 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 176,727 Value ($000) $9,253 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 191,555 Value ($000) $7,792 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 139,310 Value ($000) $5,149 Avg Close $37.66 Range $32.83 - $42.82
Q1 2023
Shares 45,000 Value ($000) $1,719 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 96,000 Value ($000) $5,462 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 96,000 Value ($000) $3,796 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 96,000 Value ($000) $4,224 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 32,000 Value ($000) $1,276 Avg Close $35.62 Range $31.36 - $42.33
Q2 2014
Shares 1,200 Value ($000) $12 Avg Close $8.48 Range $6.88 - $12.97
Q1 2014
Shares 66,075 Value ($000) $839 Avg Close $14.84 Range $11.28 - $18.18
Q4 2013
Shares 112,697 Value ($000) $1,689 Avg Close $12.86 Range $9.33 - $16.36
Q3 2013
Shares 147,697 Value ($000) $1,631 Avg Close $8.33 Range $6.51 - $12.15
Q2 2013
Shares 83,622 Value ($000) $664 Avg Close $6.37 Range $5.03 - $8.49